Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleExperimental Studies

Development of a Drug Delivery System using a Model that Mimics Chronic Infection of Mycobacterium bovis Calmette-Guérin in Alveolar Macrophages

AYA YOSHIDA, HIROYUKI INAGAWA, CHIE KOHCHI, TAKASHI NISHIZAWA, HITOSHI HORI and GEN-ICHIRO SOMA
Anticancer Research November 2007, 27 (6A) 3707-3711;
AYA YOSHIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI INAGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIE KOHCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI NISHIZAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HITOSHI HORI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEN-ICHIRO SOMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sma5628{at}tokushima.bunri-u.ac.jp
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Macrophages play a dominant role in defense against infective organisms and their regarded abilities can be positioned as their most primitive and important function. On the other hand, tuberculosis, caused by tubercle bacilli which possess the ability to survive in phagosome and grow in cell, poses a serious problem as an intractable disease because the efficacy of drug delivery to the target bacilli is low. We have developed a new approach to therapy against intracellular bacteria using a drug delivery system (DDS), to deliver an effective amount of drug to the target site, based on the phagocytotic ability of macrophages. In this review, the development of an in vitro model of chronic infection by tubercle bacilli and therapy against tuberculosis using phagocytosis by macrophages and a DDS with microspheres are described.

  • Macrophage
  • phagocytosis
  • tubercuolosis
  • poly (DL-lactic-co-glycolic) acid
  • drug delivery systems
  • review

Footnotes

  • Received April 23, 2007.
  • Revision received August 24, 2007.
  • Accepted August 30, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 6A
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of a Drug Delivery System using a Model that Mimics Chronic Infection of Mycobacterium bovis Calmette-Guérin in Alveolar Macrophages
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 18 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Development of a Drug Delivery System using a Model that Mimics Chronic Infection of Mycobacterium bovis Calmette-Guérin in Alveolar Macrophages
AYA YOSHIDA, HIROYUKI INAGAWA, CHIE KOHCHI, TAKASHI NISHIZAWA, HITOSHI HORI, GEN-ICHIRO SOMA
Anticancer Research Nov 2007, 27 (6A) 3707-3711;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Development of a Drug Delivery System using a Model that Mimics Chronic Infection of Mycobacterium bovis Calmette-Guérin in Alveolar Macrophages
AYA YOSHIDA, HIROYUKI INAGAWA, CHIE KOHCHI, TAKASHI NISHIZAWA, HITOSHI HORI, GEN-ICHIRO SOMA
Anticancer Research Nov 2007, 27 (6A) 3707-3711;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
  • MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire